Profile data is unavailable for this security.
About the company
Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.
- Revenue in SEK (TTM)0.00
- Net income in SEK-7.46m
- Incorporated2011
- Employees--
- LocationToleranzia ABErik Dahlbergsgatan 11AGOETEBORG 411 26SwedenSWE
- Websitehttps://www.toleranzia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioextrax AB publ | 2.06m | -21.51m | 80.97m | -- | -- | 3.37 | -- | 39.36 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Immunovia AB (publ) | 1.58m | -309.44m | 80.97m | 11.00 | -- | 1.21 | -- | 51.41 | -8.27 | -8.27 | 0.0412 | 1.48 | 0.0079 | 74.81 | 7.89 | 143,181.80 | -155.00 | -41.33 | -179.24 | -44.24 | -4,687.68 | -7,553.76 | -19,646.92 | -20,879.26 | 2.69 | -22.84 | 0.1329 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Sprint Bioscience AB | 50.49m | -441.00k | 87.41m | 28.00 | -- | 3.15 | 12,487.82 | 1.73 | -0.0064 | -0.0064 | 0.7232 | 0.3978 | 1.01 | -- | 7.58 | 1,803,036.00 | -0.8838 | -71.22 | -1.58 | -113.71 | 82.77 | 62.75 | -0.8735 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 87.54m | -- | -- | 0.5349 | -- | 2.03 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Biosergen AB | 0.00 | -27.04m | 89.39m | 3.00 | -- | 11.52 | -- | -- | -0.4007 | -0.4007 | 0.00 | 0.0418 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.25 | -- | -- | -- |
| NextCell Pharma AB | 12.22m | -40.69m | 90.42m | -- | -- | 1.37 | -- | 7.40 | -1.18 | -1.18 | 0.3555 | 1.92 | 0.124 | 14.66 | 6.80 | -- | -41.28 | -34.92 | -45.63 | -37.06 | 6.61 | -68.21 | -332.90 | -538.60 | 4.97 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -44.05m | 94.62m | 4.00 | -- | 5.03 | -- | -- | -0.189 | -0.189 | 0.00 | 0.0543 | 0.00 | -- | -- | 0.00 | -138.88 | -125.42 | -179.93 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Bactiquant A/S | 19.25m | -20.50m | 95.58m | -- | -- | 4.24 | -- | 4.97 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
| Ziccum AB | 3.75m | -21.41m | 97.87m | -- | -- | 10.30 | -- | 26.12 | -1.54 | -1.54 | 0.2703 | 0.6191 | 0.1553 | -- | 2.01 | -- | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -- | -- |
| Dextech Medical AB | 0.00 | -4.57m | 99.82m | 1.00 | -- | 3.09 | -- | -- | -0.2473 | -0.2473 | 0.00 | 1.75 | 0.00 | -- | -- | -- | -13.04 | -28.96 | -13.21 | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Scandion Oncology A/S | 0.00 | -61.33m | 100.96m | 4.00 | -- | 2.07 | -- | -- | -1.52 | -1.52 | 0.00 | 1.20 | 0.00 | -- | -- | 0.00 | -63.25 | -45.09 | -76.67 | -52.65 | -- | -- | -- | -- | -- | -- | 0.0158 | -- | -- | -- | 48.89 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.46m | 102.48m | -- | -- | 0.6675 | -- | -- | -0.0597 | -0.0597 | 0.00 | 0.779 | 0.00 | -- | -- | -- | -5.21 | -7.45 | -5.43 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Wntresearch AB | 0.00 | -32.47m | 104.79m | 2.00 | -- | 0.6597 | -- | -- | -0.1108 | -0.1108 | 0.00 | 0.1834 | 0.00 | -- | -- | -- | -134.87 | -100.71 | -166.68 | -123.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.65 | -- | -- | -- |
| Isofol Medical AB (publ) | 721.00k | -37.07m | 119.36m | 3.00 | -- | 0.9829 | -- | 165.55 | -0.2164 | -0.2164 | 0.0044 | 0.7518 | 0.0041 | -- | 0.0728 | 240,333.30 | -21.15 | -66.73 | -26.32 | -88.27 | -4,773.23 | -- | -5,141.61 | -1,023.62 | -- | -- | -- | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| Opticept Technologies AB | 9.15m | -80.36m | 120.07m | 29.00 | -- | 0.3264 | -- | 13.13 | -2.51 | -2.51 | 0.2844 | 8.72 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.18 | -46.20 | 125.88 | 62.65 | -879.64 | -882.41 | 0.6216 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
| AlzeCure Pharma AB | 0.00 | -37.17m | 124.17m | 11.00 | -- | 5.22 | -- | -- | -0.5986 | -0.5986 | 0.00 | 0.3829 | 0.00 | -- | -- | 0.00 | -72.28 | -52.78 | -88.22 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
Data as of Apr 19 2024. Currency figures normalised to Toleranzia AB's reporting currency: Swedish Krona SEK
